Abstract
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, which involves the mutation of the G6PD gene on the X chromosome, is the most common enzyme defect in humans. G6PD produces nicotinamide adenine dinucleotide phosphate (NADPH) for red blood cell protection from oxidative stress. Oxidative stress-induced red blood cell hemolysis in G6PD-deficient patients leads to anemia, jaundice, acute renal failure, and kernicterus in newborns. Currently, the fluorescent spot test (FST) is widely used for G6PD deficiency screening. This test detects NADPH production under UV light. This study purposed to modify the G6PD deficiency screening test based on NADPH production and the ability to detect the results of the color change in the color of the reaction. Blood samples of 60 subjects were collected and screened for G6PD deficiency using FST method. All samples were tested with the modified G6PD screening test and the quantitative assay kit. The results from the modified test showed the color red for normal cases, whereas the color brown indicated G6PD deficiency cases. The cutoff value of G6PD activity detected by the quantitative method was less than 2.9 U/gHb for G6PD deficiency. The precision of this study was 100 %. The results of sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of the modified test were 100 %, 96.7 %, 100 %, and 96.7 %, respectively. The modified G6PD screening test can be used for the screening of G6PD deficiency in newborns, for support through providing more information, and for self-protection from oxidative stress.
Similar content being viewed by others
References
Stanton RC (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64(5):362–369
Tang HY, Ho HY, Wu PR, Chen SH, Kuypers FA, Cheng ML, Chiu DT (2015) Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal 22(9):744–759
Nobrega-Pereira S, Fernandez-Marcos PJ, Brioche T, Gomez-Cabrera MC, Salvador-Pascual A, Flores JM et al (2016) G6PD protects from oxidative damage and improves healthspan in mice. Nat Commun 7:10894
Van den Broek L, Heylen E, Van den Akker M (2016) Glucose-6-phosphate dehydrogenase deficiency: not exclusively in males. Clin Case Rep 4(12):1135–1137
Gomez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, González-Valdez A et al (2016) Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world. Int J Mol Sci 17(12):2069
Ley B, Thriemer K, Jaswal J et al (2017) Barriers to routine G6PD testing prior to treatment with primaquine. Malar J 16:329
Satyagraha AW, Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U et al (2016) Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural Eastern Indonesia. PLoS Negl Trop Dis 10(2):e0004457
Mbanefo EC, Ahmed AM, Titouna A, Elmaraezy A, Trang NTH, Phuoc Long N et al (2017) Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep 7:45963
Von Fricken M, Weppelmann T, Eaton W, Masse R, Madsen VE, De Rochars B et al (2014) Performance of the carestart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg 91:77–80
Osorio L, Carter N, Arthur P, Bancone G, Gopalan S, Gupta SK et al (2015) Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjects. Am J Trop Med Hyg 92(1):22–27
Esperanza Espino F, Bibit JA, Beulah Sornillo J, Tan A, von Seidlein L, Ley B (2016) Comparison of three screening test kits for G6PD enzyme deficiency: implications for its use in the radical cure of vivax malaria in remote and resource-poor areas in the Philippines. PLoS ONE 11(2):e0148172
Markic J, Krzelj V, Markotic A, Marusic E, Stricevic L, Zanchi J, Sapunar A (2006) High incidence of glucose-6-phosphate dehydrogenase deficiency in Croatian island isolate: example from Vis island. Croat Croat Med J 47(4):556–570
Rawat DK, Hecker P, Watanabe M, Chettimada S, Levy RJ, Okada T et al (2012) Glucose-6-phosphate dehydrogenase and NADPH redox regulates cardiac myocyte L-type calcium channel activity and myocardial contractile function. PLoS ONE 7(10):e45365
Obasa T, Mokuolu O, Ojuawo A (2011) Glucose 6 phosphate dehydrogenase levels in babies delivered at the University of Ilorin teaching hospital. Niger J Paediatr 38(4):165–169
Obasa TO, Adesiyun OO, Mokuolu OA, Ojuawo AI (2012) Comparative analysis of glucose-6-phosphate dehydrogenase levels in pre-term and term babies delivered at University of Ilorin Teaching Hospital. Pediatr Rep 4(1):e7
Mukherjee MB, Colah RB, Martin S, Ghosh K (2015) Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India-Country scenario. Indian J Med Res 141(5):516–520
Elella SA, Tawfik M, Barseem N, Moustafa W (2017) Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates in Egypt. Ann Saudi Med 37(5):362–365
Charoenkwan P, Tantiprabha W, Sirichotiyakul S, Phusua A, Sanguansermsri T (2014) Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in northern Thailand. Southeast Asian J Trop Med Public Health 45(1):187–193
Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R et al (2011) Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 10:368
Dombrowski JG, Souza RM, Curry J, Hinton L, Silva NRM, Grignard L et al (2017) G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon. Malar J 6(1):253
LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S et al (2014) Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg 91(4):854–861
Nantakomol D, Paul R, Palasuwan A, Day NPJ, White NJ, Imwong M (2013) Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiency. Malar J 12:289
Neill JM (1925) Studies on the oxidation reduction of hemoglobin and methemoglobin: III. The formation of methemoglobin during the oxidation of autoxidizable substances. J Exp Med 41(4):551–560
Santana MS, de Lacerda MVG, Barbosa MdGV, Alecrim WD, Alecrim MdGC (2009) Glucose-6-phosphate dehydrogenase deficiency in an endemic area for malaria in Manaus: a cross-sectional survey in the Brazilian Amazon. PLoS ONE 4(4):e5259
AlSaif S, Ponferrada MB, AlKhairy K, AlTawil K, Sallam A, Ahmed I et al (2017) Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples. BMC Pediatr 17(1):159
Luzzatto L, Seneca E (2014) G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 164(4):469–480
Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P et al (2013) G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J 12:391
Acknowledgements
This work has been supported by the Graduate Scholarship for Outstanding Students (Grant number 07/2560 and 07/2562) and the Institute of Research and Innovation, Walailak University, under grant number WU_IRG61_18.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krithong, R., Nuinoon, M., Pramtong, S. et al. The modified G6PD deficiency screening test. Accred Qual Assur 25, 121–126 (2020). https://doi.org/10.1007/s00769-019-01421-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00769-019-01421-8